Expertise in
6
conditions

Emmanuel Mahe

Argenteuil, FR 
Expertise in
6
conditions
Argenteuil, FR 

Overview

Emmanuel Mahe practices practicing medicine in Argenteuil, France.

Mr. Mahe is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Psoriasis, Guttate Psoriasis, Plaque Psoriasis, and Atopic Dermatitis.

He is actively involved in clinical research, co-authoring 220 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Argenteuil, France
Other Locations
Montigny-sur-loing, France
CHU Rennes
Rennes, 35000, France
Le Mans, France
Paris, France
Tours, France
Besancon, France
Rue Du Friscaty, Thionville, 57100, France
Toulouse, France
Boulogne-billancourt, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Outpatient Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Baricitinib in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: August 05, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, Topical Corticosteroid
Study Phase: Phase 3
Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Randomized Double Blind Double Dummy Control Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid
Enrollment Status: Active_not_recruiting
Publish Date: June 10, 2026
Intervention Type: Drug
Study Drugs: Rituximab, Cyclophosphamide
Study Phase: Phase 3
View 1 Less Clinical Trial

220 Total Publications

Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.
Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies.
Journal: The New England journal of medicine
Published: May 06, 2026

Frequently Asked Questions about Emmanuel Mahe

Is Emmanuel Mahe a top-rated expert for Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Emmanuel Mahe is classified as an Elite expert for Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Emmanuel Mahe participate in research or clinical trials?

Yes. Emmanuel Mahe has published 220 articles and abstracts on conditions like Psoriasis. You can view a list of Emmanuel Mahe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mahe's expertise for a condition
ConditionClose
View All 55 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile